Zanzibar Health Authority Withdraws Zinc Medication Batch Due to Quality Concerns
The Zanzibar Food, Drugs and Cosmetics Agency (ZFDA) has initiated an urgent product recall for a specific batch of PED Zinc Sulphate Dispersible Tablets after discovering critical quality issues.
The affected batch, numbered 2203002, was manufactured on March 1, 2022, and carries an expiration date of February 28, 2025. Health centers reported that the tablets were producing an unusual cloudy residue, prompting a comprehensive investigation.
Following detailed laboratory analysis, ZFDA confirmed the batch failed essential quality tests and is unsuitable for human consumption. The agency has issued immediate directives to healthcare professionals, importers, distributors, and retailers.
Key Actions Implemented:
– Immediate halt of batch distribution
– Complete removal from market circulation
– Instructions for returning affected tablets
– Separation and isolation of potentially compromised stock
Health professionals and consumers are advised to:
– Identify and avoid the specific batch
– Return tablets to original point of purchase
– Report any suspected quality issues
This recall represents ZFDA’s commitment to maintaining stringent pharmaceutical safety standards and protecting public health. Consumers are encouraged to remain vigilant and report any concerns about medical products.
The agency continues its proactive market monitoring to ensure ongoing product safety and regulatory compliance.
